Cargando…
Circadian rhythm biomarker from wearable device data is related to concurrent antidepressant treatment response
Major depressive disorder (MDD) is associated with circadian rhythm disruption. Yet, no circadian rhythm biomarkers have been clinically validated for assessing antidepressant response. In this study, 40 participants with MDD provided actigraphy data using wearable devices for one week after initiat...
Autores principales: | Ali, Farzana Z., Parsey, Ramin V., Lin, Shan, Schwartz, Joseph, DeLorenzo, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148831/ https://www.ncbi.nlm.nih.gov/pubmed/37120493 http://dx.doi.org/10.1038/s41746-023-00827-6 |
Ejemplares similares
-
Gradient boosting decision-tree-based algorithm with neuroimaging for personalized treatment in depression
por: Ali, Farzana Z., et al.
Publicado: (2022) -
Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial
por: Hill, Kathryn R., et al.
Publicado: (2021) -
Human circadian rhythm studies: Practical guidelines for inclusion/exclusion criteria and protocol
por: Yousefzadehfard, Yashar, et al.
Publicado: (2022) -
Is Advancing Circadian Rhythm the Mechanism of Antidepressants?
por: Lee, Heon-Jeong
Publicado: (2019) -
Alcohol, Antidepressants, and Circadian Rhythms: Human and Animal Models
por: Rosenwasser, Alan M.
Publicado: (2001)